Literature DB >> 6298709

Cloning and expression of the cDNA for human antithrombin III.

S C Bock, K L Wion, G A Vehar, R M Lawn.   

Abstract

A partial cDNA clone for human antithrombin III (ATIII) was obtained by screening a cDNA library prepared from size fractionated liver RNA with a pool of eight 16-base long synthetic DNA fragments whose sequence was determined from protein sequence data. A fragment of the partial cDNA clone was used to enrich RNA for ATIII messages, and cDNA clones encoding the entire ATIII structural gene were identified. The complete nucleotide and predicted amino acid sequences of human ATIII and its 32 residue signal peptide are reported, and provide further opportunity to compare the ATIII primary structure with corresponding regions from homologous proteins, alpha 1-antitrypsin and ovalbumin. Plasmids in which the structural genes for mature and pre-ATIII were linked to the E. coli trp promoter-operator support the synthesis of human antithrombin III and pre-antithrombin III in bacteria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6298709      PMCID: PMC327073          DOI: 10.1093/nar/10.24.8113

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Nucleic acid hybridization using DNA covalently coupled to cellulose.

Authors:  B E Noyes; G R Stark
Journal:  Cell       Date:  1975-07       Impact factor: 41.582

3.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

4.  Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.

Authors:  G Sas; G Blaskó; D Bánhegyi; J Jákó; L A Pálos
Journal:  Thromb Diath Haemorrh       Date:  1974-09-30

5.  Value of Normotest and antithrombin 3 in the assessment of liver function.

Authors:  L Mannucci; N Dioguardi; E Del Ninno; P M Mannucci
Journal:  Scand J Gastroenterol Suppl       Date:  1973

6.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

7.  Inhibition of the thrombin-fibrinogen reaction by heparin and purified cofactor.

Authors:  U Abildgaard
Journal:  Scand J Haematol       Date:  1968

8.  Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.

Authors:  U Abildgaard; M K Fagerhol; O Egeberg
Journal:  Scand J Clin Lab Invest       Date:  1970-12       Impact factor: 1.713

9.  Antithrombin-3 deficiency in a Dutch family.

Authors:  J van der Meer; E A Stoepman-van Dalen; J M Jansen
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

10.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20
View more
  34 in total

1.  Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor.

Authors:  E Remold-O'Donnell; J Chin; M Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.

Authors:  I Björk; K Ylinenjärvi; S T Olson; P Hermentin; H S Conradt; G Zettlmeissl
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

3.  Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA: close homology to the serine antiproteases.

Authors:  I L Flink; T J Bailey; T A Gustafson; B E Markham; E Morkin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Competition between the signal sequence and a 3'UTR localisation signal during redirection of beta-globin mRNA to the endoplasmic reticulum: implications for biotechnology.

Authors:  K A Partridge; A Johannessen; A Tauler; I F Pryme; J E Hesketh
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

5.  Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.

Authors:  I Björk; K Nordling; E Raub-Segall; U Hellman; S T Olson
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

6.  Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

Authors:  R W Niessen; F Rezaee; P H Reitsma; M Peters; J J de Vijlder; A Sturk
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

Review 7.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

8.  Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.

Authors:  E Ersdal-Badju; A Lu; X Peng; V Picard; P Zendehrouh; B Turk; I Björk; S T Olson; S C Bock
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

10.  Characterization of an unusual DNA length polymorphism 5' to the human antithrombin III gene.

Authors:  S C Bock; D J Levitan
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.